-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Opinion|Videos|April 4, 2025

Optimizing Bispecific Antibody Administration With EHR and Technology Solutions

Experts discuss the role of technology, such as electronic health record (EHR) integration, in improving the operationalization of bispecific antibodies.

Video content above is prompted by the following:

What role does technology, such as EHR integration, play in improving the operationalization of bispecific antibodies?


Related to this article

Andrew D. Zelenetz, MD, PhD, is the chair of the NCCN B-cell Lymphomas panel.  | Image: LinkedIn
The National Comprehensive Cancer Network update on mantle cell lymphoma puts covalent BTK inhibitors, MRD testing, and TP53 sequencing at the center of frontline care, while adding pirtobrutinib and a pair of CAR T-cell therapies for disease that progresses on a BTK inhibitor.